Trudy Vanhove

Chief Medical Officer at Surrozen

Dr. Trudy Vanhove has more than 20 years of clinical drug development and medical affairs experience across small and large biopharmaceutical companies. Dr. Vanhove previously served as Vice President of medical affairs and, subsequently, R&D search and evaluation at Jazz Pharmaceuticals. Prior to Jazz Pharmaceuticals, she was Vice President, medical affairs at Depomed, Vice President clinical development at NeurogesX and a Medical Director and project team leader at XOMA. She began her career as a Medical Director at Abbott Laboratories in 1996. Dr. Vanhove earned an M.D. and a Ph.D. in pharmacology from the Catholic University in Leuven, Belgium. She completed a fellowship in clinical pharmacology at Stanford University and received an M.B.A. from St. Mary’s College in California. Dr. Vanhove has authored, or co-authored, dozens of peer-reviewed articles, and is an inventor on numerous patents.

Location

Menlo Park, United States

Links

Previous companies


Org chart

No direct reports

Teams


Offices

This person is not in any offices


Surrozen

Surrozen is a biotechnology company focused on discovering and developing novel regenerative medicines with a focus on unlocking the powerful self-renewal properties of the body through specific control of the Wnt signaling pathway.


Industries

Employees

51-200

Links